login
login

Europe Daily Bulletin No. 9195

19 May 2006
Contents Publication in full By article 38 / 43
ECONOMIC INTERPENETRATION / (eu) pharmacy

British group ASTRAZENECA will be buying out the bio-tech laboratory CAT - CAMBRIDGE ANTIBODY TECHNOLOGY, in which it already had a 19.2% stake, for £ 567 million. The offer stands at 1320 pence per share.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION